Joanna Czerwik-Marcinkowska

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

Genes

Journal of clinical medicine

Nutrients

Biology

The Jan Kochanowski University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The Jan Kochanowski University Nov 05 2018

Poland

Ph.D. Assoc.Prof. :: Department of Botany

Publications

Szymon Zmorzynski, Aleksandra Kimicka-Szajwaj, Angelika Szajwaj, Joanna Czerwik-Marcinkowska, Jacek Wojcierowski
Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment. Genes 15 (1) (2024)
Szymon Zmorzynski, Aleksandra Kimicka-Szajwaj, Angelika Szajwaj, Joanna Czerwik-Marcinkowska, Jacek Wojcierowski
Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment. Genes 15 (1) (2024)
Szymon Zmorzynski, Aleksandra Kimicka-Szajwaj, Angelika Szajwaj, Joanna Czerwik-Marcinkowska, Jacek Wojcierowski
Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment. Genes 15 (1) (2024)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Szymon Zmorzynski, Aleksandra Kimicka-Szajwaj, Angelika Szajwaj, Joanna Czerwik-Marcinkowska, Jacek Wojcierowski
Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment. Genes 15 (1) (2024)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Aneta Szudy-Szczyrek, Paul Dudek, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma. Journal of clinical medicine 12 (6) (2023)
Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Aneta Szudy-Szczyrek, Paul Dudek, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma. Journal of clinical medicine 12 (6) (2023)
Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Sylwia Chocholska, Aneta Szudy-Szczyrek, Marzena Samardakiewicz, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment. Cancers 15 (19) (2023)
Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Aneta Szudy-Szczyrek, Paul Dudek, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma. Journal of clinical medicine 12 (6) (2023)
Janusz Łuszczyński, Edyta Adamska, Anna Wojciechowska, Joanna Czerwik-Marcinkowska
Diversity Patterns of Macrofungi in Xerothermic Grasslands from the Nida Basin (Małopolska Upland, Southern Poland): A Case Study. Biology 11 (4) (2022)
Jolanta Bąk-Badowska, Anna Wojciechowska, Joanna Czerwik-Marcinkowska
Effects of Open and Forest Habitats on Distribution and Diversity of Bumblebees ( Bombus ) in the Małopolska Upland (Southern Poland): Case Study. Biology 10 (12) (2021)
Grażyna Świderska-Kołacz, Małgorzata Jefimow, Jolanta Klusek, Norbert Rączka, Szymon Zmorzyński, Anna Wojciechowska, Iwona Stanisławska, Marek Łyp, Joanna Czerwik-Marcinkowska
Influence of Algae Supplementation on the Concentration of Glutathione and the Activity of Glutathione Enzymes in the Mice Liver and Kidney. Nutrients 13 (6) (2021)
Joanna Ślusarczyk, Edyta Adamska, Joanna Czerwik-Marcinkowska
Fungi and Algae as Sources of Medicinal and Other Biologically Active Compounds: A Review. Nutrients 13 (9) (2021)
Joanna Czerwik-Marcinkowska, Renata Piwowarczyk, Bohuslav Uher, Ewa Tomal, Anna Wojciechowska
X-ray Fluorescence Techniques in Determining the Habitat Preferences of Species-Ulva pilifera (Ulvales, Chlorophyta) from Montenegro Case Study. Molecules (Basel, Switzerland) 25 (21) (2020)

Joanna Czerwik-Marcinkowska.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Joanna Czerwik-Marcinkowska